We are live on
!
Find out more
Zevra Therapeutics
ZVRA
ZVRA
36 hedge funds and large institutions have $17.8M invested in Zevra Therapeutics in 2016 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 13 increasing their positions, 8 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
63% more repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 8
10% less funds holding
Funds holding: 40 → 36 (-4)
39% less capital invested
Capital invested by funds: $29M → $17.8M (-$11.2M)
67% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 6
Holders
36
Holders Change
-4
Holders Change %
-10%
% of All Funds
0.9%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
13
Reduced
8
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
DA
DSC Advisors
Chicago,
Illinois
|
+$1.98M |
| 2 |
Creative Planning
Overland Park,
Kansas
|
+$126K |
| 3 |
Alyeska Investment Group
Chicago,
Illinois
|
+$121K |
| 4 |
Bank of New York Mellon
New York
|
+$74.6K |
| 5 |
AWA
Arete Wealth Advisors
Chicago,
Illinois
|
+$62.1K |
